The Scientist

» hemophilia

Most Recent

Pharmaceutical giant Sanofi to take over hemophilia drugmaker Biovertiv, while Celgene will buy cancer drugmaker Juno Therapeutics.

0 Comments

Sangamo Therapeutics will use zinc finger nucleases to introduce the gene for a missing clotting factor into the livers of men with hemophilia B.

2 Comments

image: Targeting DNA

Targeting DNA

By Jef Akst | June 1, 2012

After 20 years of high-profile failure, gene therapy is finally well on its way to clinical approval.

13 Comments

image: Gene Editing Treats Blood Disease

Gene Editing Treats Blood Disease

By Annie Gottlieb | June 27, 2011

Revising a dysfunctional gene in vivo for the first time, researchers successfully restore blood clotting in hemophiliac mice.

0 Comments

Popular Now

  1. Two University of Rochester Professors Resign in Protest
  2. Dartmouth Professor Investigated for Sexual Misconduct Retires
  3. Theranos Leaders Indicted For Fraud
    The Nutshell Theranos Leaders Indicted For Fraud

    Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

  4. Koko the Signing Gorilla Dies at 46